Estimating the Risk for Secondary Cancer After Targeted α-Therapy with 211 At Intraperitoneal Radioimmunotherapy.
- Resource Type
- Article
- Source
- Journal of Nuclear Medicine; Jan2023, Vol. 64 Issue 1, p165-172, 8p
- Subject
- Language
- ISSN
- 01615505